Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02463552
Other study ID # UFSergipe
Secondary ID
Status Completed
Phase N/A
First received May 29, 2015
Last updated October 24, 2016
Start date May 2015
Est. completion date October 2016

Study information

Verified date October 2016
Source Universidade Federal de Sergipe
Contact n/a
Is FDA regulated No
Health authority Brazil: National Health Surveillance Agency
Study type Interventional

Clinical Trial Summary

This study aims to evaluate the effects of prior use of non-steroidal anti-inflammatory Naproxen on risk and level of tooth sensitivity caused by in-office bleaching procedures.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date October 2016
Est. primary completion date June 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

- At least 18 years old patients of both genders presenting good general/oral health;

- All maxillary anterior teeth presenting shade equal or darker than 2M2 at Vita bleachguide guide (Vita-Zahnfabrik, Germany);

- Signed the form accepting to participate of this study.

Exclusion Criteria:

- Presence of caries lesions, restorations and/or endodontic treatment at any maxillary anterior teeth.

- Undergone tooth-whitening procedures;

- Pregnant/lactating;

- Presence of periodontal diseases;

- Presence of severe tooth discoloration by tetracycline stains or fluorosis;

- Any kind of medicine, bruxism habits or any other pathology that can cause sensitivity (such as recession, dentin exposure);

- Continuous use of drugs with anti-inflammatory actions;

- Presence of tooth hypersensitivity at baseline measurement;

- Any known adverse effects caused by Naproxen;

- Non-attendance to any session of evaluation or bleaching.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Drug:
Naproxen
The patient will receive a single-dose of Naproxen (500 mg) one hour before the bleaching procedure.

Locations

Country Name City State
Brazil Universidade Federal de Sergipe Aracaju SE

Sponsors (1)

Lead Sponsor Collaborator
Universidade Federal de Sergipe

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Other Efficacy of bleaching A spectrophotometer will be used to assess the color alteration, while the parameter "L", "a" and "b" will be recorded. 7 days after bleaching procedure Yes
Primary Risk to Tooth sensitivity - during procedure The tooth sensitivity will be evaluated using a 5-point Verbal rating scale (VRS), where 0 = none, 1 = mild, 2 = moderate, 3 = considerable and 4 = severe. Score different from 0 will determine presence of sensitivity. The risk of tooth sensitivity will be determined by relative risk assessed by ratio between absolute risk of experimental condition by those observed in control. The 95% confidence interval will be calculated. During the bleaching procedure Yes
Secondary Level of tooth sensitivity - during procedure The tooth sensitivity will be evaluated using a 5-point Verbal rating scale (VRS), where 0 = none, 1 = mild, 2 = moderate, 3 = considerable and 4 = severe. During the bleaching procedure Yes
Secondary Risk of tooth sensitivity - after procedure The tooth sensitivity will be evaluated using a 5-point Verbal rating scale (VRS), where 0 = none, 1 = mild, 2 = moderate, 3 = considerable and 4 = severe. Score different from 0 will determine presence of sensitivity. The risk of tooth sensitivity will be determined by relative risk assessed by ratio between absolute risk of experimental condition by those observed in control. The 95% confidence interval will be calculated. 24 hours after bleaching prcedure Yes
Secondary Level of tooth sensitivity - after procedure The tooth sensitivity will be evaluated using a 5-point Verbal rating scale (VRS), where 0 = none, 1 = mild, 2 = moderate, 3 = considerable and 4 = severe. 24 hours after bleaching prcedure Yes
See also
  Status Clinical Trial Phase
Withdrawn NCT02841514 - The Efficacy and Safety of Tooth Bleaching Procedure Using Y10 Whitening Toothpaste and RF Current N/A
Recruiting NCT03588871 - Comparison of the Efficacy and Quality of Life of Three Bleaching Products Phase 4
Completed NCT05725850 - The Effect of an Experimental Gel Based on Acmella Oleracea Extract in Reducing Post-bleaching Tooth Sensitivity N/A
Completed NCT02942082 - Clinical Evaluation for Post Bleaching Hypersensitivity Using Desensitizing Agent During In-office Bleaching N/A
Completed NCT04238429 - Whitening Efficacy of Dentifrice Containing 10% High Cleaning Silica, 0.5% Sodium Phytate and 0.5% Sodium Pyrophosphate N/A
Recruiting NCT05202093 - Eight Week Clinical Study to Investigate Reduction of Extrinsic Tooth Stain by Electric Toothbrush N/A
Recruiting NCT04013659 - Effect of Gel Renewal During In-office Dental Bleaching Phase 1
Completed NCT02353611 - Safety and Efficacy of a 6% Hydrogen Peroxide Tooth Bleaching Agent N/A
Completed NCT03207204 - In-office Bleaching Using a Violet Light N/A
Completed NCT05021965 - The Effectiveness of At-home , In-office and Combined Dental Bleaching System :A Randomized Controlled Clinical Trial N/A
Completed NCT03514290 - Effect of Low-level Laser Therapy on Post-bleaching Sensitivity and Color Change N/A
Completed NCT04855279 - Prevention of Bleaching Induced Sensitivity N/A
Not yet recruiting NCT06180707 - Pregabalin Gel in Reducing Post-operative Tooth Sensitivity Surgery Caused by Bleaching With 35% Hydrogen Peroxide Phase 3
Completed NCT03039270 - Evaluation of Sensitivity With and Without Sonic Activation of a Desensitizing Gel Before in Office Bleaching in Adults N/A
Completed NCT03089216 - Combined Bleaching Technique: Efficacy and Tooth Sensitivity Phase 4